Solving the TED Puzzle: Answering Your Questions on Diagnosis to Decision-Making

Thyroid eye disease (TED) is a complex, autoimmune-mediated, inflammatory disorder of the orbit that presents with a range of symptoms, including ocular pain, dysmotility, and changes in ocular structure and function. The disease severely impacts patients' quality of life, often resulting in persistent discomfort, altered appearance, and impaired vision even after the acute phase subsides. Traditional treatments such as steroids, radiotherapy, and surgery, do not alter the disease's course, whereas newer biologic therapies show promise in improving outcomes. Despite these advances, managing TED remains challenging due to its heterogeneous presentation and the need for early diagnosis and intervention. Emerging therapies targeting specific pathways offer hope for improved disease control and quality of life. In this CE activity, expert faculty review disease burden and differential diagnosis as well as assess benefit-risk evaluations for clinical decision-making in treating patients with TED.